Health Tech Capitol | Propeller signs another major respiratory partner, Novartis
15752
post-template-default,single,single-post,postid-15752,single-format-standard,tribe-no-js,tribe-bar-is-disabled,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-9.3,wpb-js-composer js-comp-ver-4.12,vc_responsive

Propeller signs another major respiratory partner, Novartis

08 Feb Propeller signs another major respiratory partner, Novartis

Posted at 15:44h in Uncategorized by
0 Likes

Madison, Wisconsin-based Propeller Health has landed its third major pharma client, paving the way for its add-on sensors and digital health platform to connect with patients and physicians using Novartis Pharma’s chronic obstructive pulmonary disease (COPD) inhalers.

Announced Wednesday, the deal centers around the Breezhaler inhaler, a device used by a portfolio of Novartis COPD treatments.

Propeller has previously collaborated with Boehringer Ingelheim and GlaxoSmithKline, along with U.K.-based Vectura and Aptar Pharma, a leading developer of metered dose inhalers systems.

Read more at MedCity News

No Comments

Sorry, the comment form is closed at this time.